VeroScience, LLC

Biotechnology ResearchRhode Island, United States2-10 Employees

VeroScience, LLC is a biotechnology research company based in Tiverton, Rhode Island, focused on exploring how biological clocks in vertebrates govern neuroendocrine regulation to inform new treatments for metabolic and immune-related disorders. The organization seeks to translate natural regulatory mechanisms into therapeutic strategies aimed at correcting pathological biochemistry toward normal physiology, rather than developing single product solutions. A key platform underlying their work is Circadian Neuroendocrine Resetting Therapy, which informs multiple therapeutic approaches for chronic diseases, including type 2 diabetes, metabolic syndrome, autoimmune disease, and cancer. The company’s work is grounded in interdisciplinary basic research, with Cycloset, a morning-dosed formulation of bromocriptine mesylate, having FDA approval as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Established in Rhode Island, VeroScience operates on a small team and conducts research aimed at developing treatment strategies rather than marketed products, reflecting its focus on fundamental biological mechanisms and their clinical implications.

Sign up for free to view info

Email Format Employee directory